Discovery of anticancer agents of diverse natural origin

被引:71
作者
Kinghorn, A. Douglas [1 ]
de Blanco, Esperanza J. Carcache [1 ]
Chail, Hee-Byung [1 ]
Orjala, Jimmy [2 ]
Farnsworth, Norman R. [2 ]
Soejarto, D. Doel [2 ]
Oberlies, Nicholas H. [3 ]
Wani, Mansukh C. [3 ]
Kroll, David J. [3 ]
Pearce, Cedric J. [4 ]
Swanson, Steven M. [2 ]
Kramer, Robert A. [5 ]
Rose, William C. [5 ]
Fairchild, Craig R. [5 ]
Vite, Gregory D. [5 ]
Emanuel, Stuart [5 ]
Jarjoura, David [6 ]
Cope, Frederick O. [6 ]
机构
[1] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA
[2] Univ Illinois, Coll Pharm, Chicago, IL 60612 USA
[3] Res Triangle Inst, Res Triangle Pk, NC 27709 USA
[4] Mycosynthetix Inc, Hillsborough, NC 27278 USA
[5] Bristol Myers Squibb Co, Pharmaceut Res Inst, Princeton, NJ 08543 USA
[6] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA
关键词
natural products; plants; cyanobacteria; fungi; anticancer activity; NF-KAPPA-B; PRODUCT-DERIVED COMPOUNDS; ENANTIOSELECTIVE SYNTHESIS; DRUG DISCOVERY; ACULEATIN-A; ROCAGLAMIDE DERIVATIVES; ABSOLUTE-CONFIGURATIONS; PROTEASOME INHIBITION; FUNGAL METABOLITE; CANCER;
D O I
10.1351/PAC-CON-08-10-16
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A collaborative multidisciplinary research project is described in which new natural product anticancer drug leads are obtained from a diverse group of organisms, constituted by tropical plants, aquatic cyanobacteria, and filamentous fungi. Information is provided on how these organisms are collected and processed. The types of bioassays are indicated in which crude extracts of these acquisitions are tested. Progress made in the isolation of lead bioactive secondary metabolites from three tropical plants is discussed.
引用
收藏
页码:1051 / 1063
页数:13
相关论文
共 97 条
[1]   Proteasome inhibition: a novel approach to cancer therapy [J].
Adams, J .
TRENDS IN MOLECULAR MEDICINE, 2002, 8 (04) :S49-S54
[2]   Phytochemical studies and cytotoxicity evaluations of Colchicum tunicatum Feinbr and Colchicum hierosolymitanum Feinbr (Colchicaceae):: two native Jordanian meadow saffrons [J].
Alali, Feras Q. ;
Tawaha, Khaled ;
El-Elimat, Tamam ;
Qasaymeh, Rana ;
Li, Chen ;
Burgess, Jason ;
Nakanishi, Yuka ;
Kroll, David J. ;
Wani, Mansukh C. ;
Oberlies, Nicholas H. .
NATURAL PRODUCT RESEARCH, 2006, 20 (06) :558-566
[3]   Enantioselective synthesis and absolute configurations of aculeatins A, B, D, and 6-epi-aculeatin D [J].
Alvarez-Bercedo, Paula ;
Falomir, Eva ;
Carda, Miguel ;
Marco, J. A. .
TETRAHEDRON, 2006, 62 (41) :9641-9649
[4]  
[Anonymous], 2008, Cancer Facts Figures 2008
[5]  
Artuso A., 1997, DRUGS NATURAL ORIGIN
[6]   Relationships between inhibitory activity against a cancer cell line panel, profiles of plants collected, and compound classes isolated in an anticancer drug discovery project [J].
Balunas, Marcy J. ;
Jones, William P. ;
Chin, Young-Won ;
Mi, Qiuwen ;
Farnsworth, Norman R. ;
Soejarto, Djaja D. ;
Cordell, Geoffrey A. ;
Swanson, Steven M. ;
Pezzuto, John M. ;
Chai, Hee-Byung ;
Kinghorn, A. Douglas .
CHEMISTRY & BIODIVERSITY, 2006, 3 (08) :897-915
[7]   Rocaglamide derivatives are potent inhibitors of NF-κB activation in T-cells [J].
Baumann, B ;
Bohnenstengel, F ;
Siegmund, D ;
Wajant, H ;
Weber, C ;
Herr, I ;
Debatin, KM ;
Proksch, P ;
Wirth, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (47) :44791-44800
[8]  
Bohnenstengel FI, 1999, Z NATURFORSCH C, V54, P1075
[9]   Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model [J].
Bordeleau, Marie-Eve ;
Robert, Francis ;
Gerard, Baudouin ;
Lindqvist, Lisa ;
Chen, Samuel M. H. ;
Wendel, Hans-Guido ;
Brem, Brigitte ;
Greger, Harald ;
Lowe, Scott W. ;
Porco, John A., Jr. ;
Pelletier, Jerry .
JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (07) :2651-2660
[10]   SOME PRACTICAL CONSIDERATIONS AND APPLICATIONS OF THE NATIONAL-CANCER-INSTITUTE IN-VITRO ANTICANCER DRUG DISCOVERY SCREEN [J].
BOYD, MR ;
PAULI, KD .
DRUG DEVELOPMENT RESEARCH, 1995, 34 (02) :91-109